InspireMD, Inc. Files Q1 2025 10-Q Report

Ticker: NSPR · Form: 10-Q · Filed: May 8, 2025 · CIK: 1433607

Inspiremd, INC. 10-Q Filing Summary
FieldDetail
CompanyInspiremd, INC. (NSPR)
Form Type10-Q
Filed DateMay 8, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: 10-Q, quarterly-report, medical-devices

TL;DR

InspireMD filed its Q1 2025 10-Q. Financials are in. Check it.

AI Summary

InspireMD, Inc. filed its quarterly report for the period ending March 31, 2025. The company, formerly Saguaro Resources, Inc., is based in Miami, Florida, and operates in the surgical and medical instruments sector. This filing covers the first quarter of 2025, with financial data from previous periods also included for comparison.

Why It Matters

This filing provides investors with an update on InspireMD's financial performance and operational status for the first quarter of 2025, crucial for understanding the company's trajectory in the medical device market.

Risk Assessment

Risk Level: medium — As a medical device company, InspireMD faces inherent risks related to product development, regulatory approvals, market adoption, and competition.

Key Numbers

Key Players & Entities

FAQ

What is the primary business of InspireMD, Inc.?

InspireMD, Inc. operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry, as indicated by its SIC code 3841.

When was the company formerly known as Saguaro Resources, Inc.?

The company changed its name from Saguaro Resources, Inc. on April 28, 2008.

What is the filing date of this 10-Q report?

This 10-Q report was filed on May 8, 2025.

What period does this 10-Q report cover?

This 10-Q report covers the period ending March 31, 2025.

Where is InspireMD, Inc. located?

InspireMD, Inc. is located in Miami, Florida, with its business and mailing address at 6303 Waterford District Drive, Suite 215.

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on May 8, 2025 regarding InspireMD, Inc. (NSPR).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing